MRTX Stock Takes A Hit After Receiving A Lowball Takeover Bid
Bristol Myers Squibb (BMY) offered to buy Mirati Therapeutics (MRTX) for up to $5.8 billion, but MRTX stock tumbled Monday ...
Bristol Myers Squibb (BMY) offered to buy Mirati Therapeutics (MRTX) for up to $5.8 billion, but MRTX stock tumbled Monday ...
wildpixel/iStock through Getty Photos Mirati Therapeutics (NASDAQ:MRTX) plunged 23% within the post-market Thursday after the clinical-stage oncology firm shared trial ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.